 | • レポートコード：QYR9ST04173 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※当調査レポートでは、婦人科癌の世界市場について調査・分析し、婦人科癌の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（化学療法、標的療法、ホルモン療法）、用途別（病院、診療所、専門癌治療センター）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の婦人科癌市場動向 ・主要企業別マーケットシェア ・婦人科癌の種類別市場規模2014-2019 （化学療法、標的療法、ホルモン療法） ・婦人科癌の用途別市場規模2014-2019 （病院、診療所、専門癌治療センター） ・婦人科癌の北米市場：主要企業・種類別/用途別市場規模 ・婦人科癌のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・婦人科癌の中国市場：主要企業・種類別/用途別市場規模 ・婦人科癌の日本国内市場：主要企業・種類別/用途別市場規模 ・婦人科癌の東南アジア市場：主要企業・種類別/用途別市場規模 ・婦人科癌のインド市場：主要企業・種類別/用途別市場規模 ・婦人科癌の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （GlaxoSmithKline、Becton Dickinson、Eli Lilly、Bristol Myers Squibb、F. Hoffmann、Apotex、AstraZeneca、Novartis、Merck、Pfizer、Teva Pharmaceutical） ・婦人科癌の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ... |
Gynecological cancers are characterized by uncontrolled growth and spread of abnormal cells. The growth of the global gynecological cancer drugs market is driven by factors such as increase in incidence of gynecological cancers, growth in importance of targeted drug therapies, rise in investment from government, public & private organizations for the development of novel drugs to treat cancer, and increase in risk factors that lead to cancer.
However, patent expiry of various major drugs is key restraint for the global gynecological cancers market. In addition, stringent regulatory hurdles also obstruct the growth of global gynecological cancers market.
United States and Europe dominates the global gynecological cancers market. The U.S. represents the largest market for gynecological cancers followed by Canada in United States. In Europe, France, Germany and the U.K. holds major share of gynecological cancers market.
In 2018, the global Gynecological Cancers market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Gynecological Cancers status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Gynecological Cancers development in United States, Europe and China.
The key players covered in this study
GlaxoSmithKline
Becton Dickinson
Eli Lilly
Bristol Myers Squibb
F. Hoffmann
Apotex
AstraZeneca
Novartis
Merck
Pfizer
Teva Pharmaceutical
Market segment by Type, the product can be split into
Chemotherapy
Targeted Therapy
Hormonal Therapy
Market segment by Application, split into
Hospitals
Clinics
Specialized Cancer Treatment Centers
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Gynecological Cancers status, future forecast, growth opportunity, key market and key players.
To present the Gynecological Cancers development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Gynecological Cancers are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Gynecological Cancers Market Size Growth Rate by Type (2014-2025)
1.4.2 Chemotherapy
1.4.3 Targeted Therapy
1.4.4 Hormonal Therapy
1.5 Market by Application
1.5.1 Global Gynecological Cancers Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Specialized Cancer Treatment Centers
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Gynecological Cancers Market Size
2.2 Gynecological Cancers Growth Trends by Regions
2.2.1 Gynecological Cancers Market Size by Regions (2014-2025)
2.2.2 Gynecological Cancers Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Gynecological Cancers Market Size by Manufacturers
3.1.1 Global Gynecological Cancers Revenue by Manufacturers (2014-2019)
3.1.2 Global Gynecological Cancers Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Gynecological Cancers Market Concentration Ratio (CR5 and HHI)
3.2 Gynecological Cancers Key Players Head office and Area Served
3.3 Key Players Gynecological Cancers Product/Solution/Service
3.4 Date of Enter into Gynecological Cancers Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Gynecological Cancers Market Size by Type (2014-2019)
4.2 Global Gynecological Cancers Market Size by Application (2014-2019)
5 United States
5.1 United States Gynecological Cancers Market Size (2014-2019)
5.2 Gynecological Cancers Key Players in United States
5.3 United States Gynecological Cancers Market Size by Type
5.4 United States Gynecological Cancers Market Size by Application
6 Europe
6.1 Europe Gynecological Cancers Market Size (2014-2019)
6.2 Gynecological Cancers Key Players in Europe
6.3 Europe Gynecological Cancers Market Size by Type
6.4 Europe Gynecological Cancers Market Size by Application
7 China
7.1 China Gynecological Cancers Market Size (2014-2019)
7.2 Gynecological Cancers Key Players in China
7.3 China Gynecological Cancers Market Size by Type
7.4 China Gynecological Cancers Market Size by Application
8 Japan
8.1 Japan Gynecological Cancers Market Size (2014-2019)
8.2 Gynecological Cancers Key Players in Japan
8.3 Japan Gynecological Cancers Market Size by Type
8.4 Japan Gynecological Cancers Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Gynecological Cancers Market Size (2014-2019)
9.2 Gynecological Cancers Key Players in Southeast Asia
9.3 Southeast Asia Gynecological Cancers Market Size by Type
9.4 Southeast Asia Gynecological Cancers Market Size by Application
10 India
10.1 India Gynecological Cancers Market Size (2014-2019)
10.2 Gynecological Cancers Key Players in India
10.3 India Gynecological Cancers Market Size by Type
10.4 India Gynecological Cancers Market Size by Application
11 Central & South America
11.1 Central & South America Gynecological Cancers Market Size (2014-2019)
11.2 Gynecological Cancers Key Players in Central & South America
11.3 Central & South America Gynecological Cancers Market Size by Type
11.4 Central & South America Gynecological Cancers Market Size by Application
12 International Players Profiles
12.1 GlaxoSmithKline
12.1.1 GlaxoSmithKline Company Details
12.1.2 Company Description and Business Overview
12.1.3 Gynecological Cancers Introduction
12.1.4 GlaxoSmithKline Revenue in Gynecological Cancers Business (2014-2019)
12.1.5 GlaxoSmithKline Recent Development
12.2 Becton Dickinson
12.2.1 Becton Dickinson Company Details
12.2.2 Company Description and Business Overview
12.2.3 Gynecological Cancers Introduction
12.2.4 Becton Dickinson Revenue in Gynecological Cancers Business (2014-2019)
12.2.5 Becton Dickinson Recent Development
12.3 Eli Lilly
12.3.1 Eli Lilly Company Details
12.3.2 Company Description and Business Overview
12.3.3 Gynecological Cancers Introduction
12.3.4 Eli Lilly Revenue in Gynecological Cancers Business (2014-2019)
12.3.5 Eli Lilly Recent Development
12.4 Bristol Myers Squibb
12.4.1 Bristol Myers Squibb Company Details
12.4.2 Company Description and Business Overview
12.4.3 Gynecological Cancers Introduction
12.4.4 Bristol Myers Squibb Revenue in Gynecological Cancers Business (2014-2019)
12.4.5 Bristol Myers Squibb Recent Development
12.5 F. Hoffmann
12.5.1 F. Hoffmann Company Details
12.5.2 Company Description and Business Overview
12.5.3 Gynecological Cancers Introduction
12.5.4 F. Hoffmann Revenue in Gynecological Cancers Business (2014-2019)
12.5.5 F. Hoffmann Recent Development
12.6 Apotex
12.6.1 Apotex Company Details
12.6.2 Company Description and Business Overview
12.6.3 Gynecological Cancers Introduction
12.6.4 Apotex Revenue in Gynecological Cancers Business (2014-2019)
12.6.5 Apotex Recent Development
12.7 AstraZeneca
12.7.1 AstraZeneca Company Details
12.7.2 Company Description and Business Overview
12.7.3 Gynecological Cancers Introduction
12.7.4 AstraZeneca Revenue in Gynecological Cancers Business (2014-2019)
12.7.5 AstraZeneca Recent Development
12.8 Novartis
12.8.1 Novartis Company Details
12.8.2 Company Description and Business Overview
12.8.3 Gynecological Cancers Introduction
12.8.4 Novartis Revenue in Gynecological Cancers Business (2014-2019)
12.8.5 Novartis Recent Development
12.9 Merck
12.9.1 Merck Company Details
12.9.2 Company Description and Business Overview
12.9.3 Gynecological Cancers Introduction
12.9.4 Merck Revenue in Gynecological Cancers Business (2014-2019)
12.9.5 Merck Recent Development
12.10 Pfizer
12.10.1 Pfizer Company Details
12.10.2 Company Description and Business Overview
12.10.3 Gynecological Cancers Introduction
12.10.4 Pfizer Revenue in Gynecological Cancers Business (2014-2019)
12.10.5 Pfizer Recent Development
12.11 Teva Pharmaceutical
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Gynecological Cancers Key Market Segments
Table Key Players Gynecological Cancers Covered
Table Global Gynecological Cancers Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Gynecological Cancers Market Size Market Share by Type 2014-2025
Figure Chemotherapy Figures
Table Key Players of Chemotherapy
Figure Targeted Therapy Figures
Table Key Players of Targeted Therapy
Figure Hormonal Therapy Figures
Table Key Players of Hormonal Therapy
Table Global Gynecological Cancers Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Specialized Cancer Treatment Centers Case Studies
Figure Gynecological Cancers Report Years Considered
Table Global Gynecological Cancers Market Size 2014-2025 (Million US$)
Figure Global Gynecological Cancers Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Gynecological Cancers Market Size by Regions 2014-2025 (Million US$)
Table Global Gynecological Cancers Market Size by Regions 2014-2019 (Million US$)
Table Global Gynecological Cancers Market Share by Regions 2014-2019
Figure Global Gynecological Cancers Market Share by Regions 2014-2019
Figure Global Gynecological Cancers Market Share by Regions 2019
Table Market Top Trends
Table Global Gynecological Cancers Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Gynecological Cancers Market Share by Manufacturers (2014-2019)
Figure Global Gynecological Cancers Market Share by Manufacturers in 2018
Table Global Gynecological Cancers Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Gynecological Cancers Product/Solution/Service
Table Date of Enter into Gynecological Cancers Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Gynecological Cancers Market Size by Type (2014-2019) (Million US$)
Table Global Gynecological Cancers Market Size Share by Type (2014-2019)
Figure Global Gynecological Cancers Market Size Market Share by Type (2014-2019)
Table Global Gynecological Cancers Market Size by Application (2014-2019) (Million US$)
Table Global Gynecological Cancers Market Size Share by Application (2014-2019)
Figure Global Gynecological Cancers Market Size Market Share by Application (2014-2019)
Figure Global Gynecological Cancers Revenue Market Share by Application in 2018
Figure United States Gynecological Cancers Market Size 2014-2019 (Million US$)
Table United States Key Players Gynecological Cancers Revenue (2018-2019) (Million US$)
Table United States Key Players Gynecological Cancers Market Share (2018-2019)
Table United States Gynecological Cancers Market Size by Type (2014-2019) (Million US$)
Table United States Gynecological Cancers Market Share by Type (2014-2019)
Table United States Gynecological Cancers Market Size by Application (2014-2019) (Million US$)
Table United States Gynecological Cancers Market Share by Application (2014-2019)
Figure Europe Gynecological Cancers Market Size 2014-2019 (Million US$)
Table Europe Key Players Gynecological Cancers Revenue (2018-2019) (Million US$)
Table Europe Key Players Gynecological Cancers Market Share (2018-2019)
Table Europe Gynecological Cancers Market Size by Type (2014-2019) (Million US$)
Table Europe Gynecological Cancers Market Share by Type (2014-2019)
Table Europe Gynecological Cancers Market Size by Application (2014-2019) (Million US$)
Table Europe Gynecological Cancers Market Share by Application (2014-2019)
Figure China Gynecological Cancers Market Size 2014-2019 (Million US$)
Table China Key Players Gynecological Cancers Revenue (2018-2019) (Million US$)
Table China Key Players Gynecological Cancers Market Share (2018-2019)
Table China Gynecological Cancers Market Size by Type (2014-20189) (Million US$)
Table China Gynecological Cancers Market Share by Type (2014-2019)
Table China Gynecological Cancers Market Size by Application (2014-2019) (Million US$)
Table China Gynecological Cancers Market Share by Application (2014-2019)
Figure Japan Gynecological Cancers Market Size 2014-2019 (Million US$)
Table Japan Key Players Gynecological Cancers Revenue (2018-2019) (Million US$)
Table Japan Key Players Gynecological Cancers Market Share (2018-2019)
Table Japan Gynecological Cancers Market Size by Type (2014-2019) (Million US$)
Table Japan Gynecological Cancers Market Share by Type (2014-2019)
Table Japan Gynecological Cancers Market Size by Application (2014-2019) (Million US$)
Table Japan Gynecological Cancers Market Share by Application (2014-2019)
Figure Southeast Asia Gynecological Cancers Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Gynecological Cancers Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Gynecological Cancers Market Share (2018-2019)
Table Southeast Asia Gynecological Cancers Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Gynecological Cancers Market Share by Type (2014-2019)
Table Southeast Asia Gynecological Cancers Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Gynecological Cancers Market Share by Application (2014-2019)
Figure India Gynecological Cancers Market Size 2014-2019 (Million US$)
Table India Key Players Gynecological Cancers Revenue (2018-2019) (Million US$)
Table India Key Players Gynecological Cancers Market Share (2018-2019)
Table India Gynecological Cancers Market Size by Type (2014-2019) (Million US$)
Table India Gynecological Cancers Market Share by Type (2014-2019)
Table India Gynecological Cancers Market Size by Application (2014-2019) (Million US$)
Table India Gynecological Cancers Market Share by Application (2014-2019)
Figure Central & South America Gynecological Cancers Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Gynecological Cancers Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Gynecological Cancers Market Share (2018-2019)
Table Central & South America Gynecological Cancers Market Size by Type (2014-2019) (Million US$)
Table Central & South America Gynecological Cancers Market Share by Type (2014-2019)
Table Central & South America Gynecological Cancers Market Size by Application (2014-2019) (Million US$)
Table Central & South America Gynecological Cancers Market Share by Application (2014-2019)
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Gynecological Cancers Business (2014-2019) (Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Gynecological Cancers Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Becton Dickinson Company Details
Table Becton Dickinson Revenue in Gynecological Cancers Business (2014-2019)(Million US$)
Figure Becton Dickinson Revenue Growth Rate in Gynecological Cancers Business (2014-2019)
Table Becton Dickinson Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Gynecological Cancers Business (2014-2019)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Gynecological Cancers Business (2014-2019)
Table Eli Lilly Recent Development
Table Bristol Myers Squibb Company Details
Table Bristol Myers Squibb Revenue in Gynecological Cancers Business (2014-2019)(Million US$)
Figure Bristol Myers Squibb Revenue Growth Rate in Gynecological Cancers Business (2014-2019)
Table Bristol Myers Squibb Recent Development
Table F. Hoffmann Company Details
Table F. Hoffmann Revenue in Gynecological Cancers Business (2014-2019)(Million US$)
Figure F. Hoffmann Revenue Growth Rate in Gynecological Cancers Business (2014-2019)
Table F. Hoffmann Recent Development
Table Apotex Company Details
Table Apotex Revenue in Gynecological Cancers Business (2014-2019)(Million US$)
Figure Apotex Revenue Growth Rate in Gynecological Cancers Business (2014-2019)
Table Apotex Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Gynecological Cancers Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Gynecological Cancers Business (2014-2019)
Table AstraZeneca Recent Development
Table Novartis Company Details
Table Novartis Revenue in Gynecological Cancers Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Gynecological Cancers Business (2014-2019)
Table Novartis Recent Development
Table Merck Company Details
Table Merck Revenue in Gynecological Cancers Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Gynecological Cancers Business (2014-2019)
Table Merck Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Gynecological Cancers Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Gynecological Cancers Business (2014-2019)
Table Pfizer Recent Development
Table Teva Pharmaceutical Company Details
Table Global Gynecological Cancers Market Size by Regions (Million US$) 2019-2025
Figure Global Gynecological Cancers Market Size Share by Regions (2019-2025)
Figure Global Gynecological Cancers Market Size Share by Regions in 2025
Figure United States Gynecological Cancers Market Size Forecast (2019-2025)(Million USD)
Figure Europe Gynecological Cancers Market Size Forecast (2019-2025)(Million USD)
Figure China Gynecological Cancers Market Size Forecast (2019-2025)(Million USD)
Figure Japan Gynecological Cancers Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Gynecological Cancers Market Size Forecast (2019-2025)(Million USD)
Figure India Gynecological Cancers Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Gynecological Cancers Market Size Forecast (2019-2025)(Million USD)
Table Global Gynecological Cancers Market Size by Product (2019-2025) (Million US$)
Figure Global Gynecological Cancers Market Size by Product (2019-2025)
Figure Global Gynecological Cancers Market Size by Product in 2025
Table Global Gynecological Cancers Market Size by Application (2019-2025) (Million US$)
Figure Global Gynecological Cancers Market Size by Application (2019-2025)
Figure Global Gynecological Cancers Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
非血液癌の世界市場：市場規模・現状・予測 Non-Hematological cancers which cover lung cancer, prostate cancer, breast cancer and others, this type of cancer are not show easily diagnosis and the treatment process is also show long that some time it lead to the death of the patient.North America has the huge number of population suffering fro…- 膵臓癌治療の世界市場：市場規模・現状・予測 Pancreatic cancer therapy is recommended by clinicians for early detection of cancer. Pancreatic cancer generally diagnosed at a later stage, since the symptoms are not easily detected or diagnosed. Factors such as, chronic inflammation of the pancreas (pancreatitis), diabetes, smoking, and obesity …
- 胃腸癌治療の世界市場：市場規模・現状・予測 Gastrointestinal Cancer Devices are various devices used to cure gastrointestinal cancer.Rise in incidences of lymphoma, adenocarcinoma, and gastrointestinal stromal tumors, increase in regulatory approvals for metastatic gastric cancer, low dose radiation technology based devices, and increase in n…
- 転移癌治療の世界市場：市場規模・現状・予測 Metastatic breast cancer is an advanced stage of breast cancer. It involves cases in which breast cancer has spread to the other parts of the body. Some of the most common organs which are affected by metastatic breast cancer are brain, liver, bones and lungs. It is also known as stage IV breast can…
- 乳がん治療の世界市場：市場規模・現状・予測 Breast cancer is the one of the most prevalent cancer and among the leading cause of death in cancer patients. According, to WHO 2013 report 50800 women died of breast cancer in 2011. Metastatic breast cancer is an advanced stage of breast cancer. It involves cases in which breast cancer has spread …